clofibride has been researched along with mianserin in 1 studies
Studies (clofibride) | Trials (clofibride) | Recent Studies (post-2010) (clofibride) | Studies (mianserin) | Trials (mianserin) | Recent Studies (post-2010) (mianserin) |
---|---|---|---|---|---|
10 | 0 | 0 | 2,624 | 539 | 488 |
Protein | Taxonomy | clofibride (IC50) | mianserin (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 3E | Homo sapiens (human) | 1.4125 | |
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.0012 | |
5-hydroxytryptamine receptor 3B | Homo sapiens (human) | 1.4125 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 0.163 | |
Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 1.078 | |
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 2.066 | |
5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.3981 | |
Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 1.9 | |
Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.32 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.0213 | |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 1.423 | |
D(2) dopamine receptor | Homo sapiens (human) | 7.0795 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.38 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.026 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.0661 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.872 | |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.21 | |
Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 1.405 | |
D(1A) dopamine receptor | Homo sapiens (human) | 0.543 | |
D(4) dopamine receptor | Homo sapiens (human) | 3.3113 | |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.21 | |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.21 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.38 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.163 | |
5-hydroxytryptamine receptor 3A | Mus musculus (house mouse) | 1.4125 | |
Histamine H2 receptor | Homo sapiens (human) | 1.008 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.083 | |
Endothelin-1 receptor | Homo sapiens (human) | 0.1148 | |
5-hydroxytryptamine receptor 1D | Homo sapiens (human) | 0.3802 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.011 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0043 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.872 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 2.068 | |
Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 2.9 | |
5-hydroxytryptamine receptor 7 | Homo sapiens (human) | 0.1148 | |
Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.4074 | |
Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.21 | |
Histamine H1 receptor | Homo sapiens (human) | 0.0024 | |
D(3) dopamine receptor | Homo sapiens (human) | 3.8905 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0073 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.19 | |
5-hydroxytryptamine receptor 3A | Homo sapiens (human) | 1.4125 | |
Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | 0.88 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.085 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 3.5481 | |
5-hydroxytryptamine receptor 3D | Homo sapiens (human) | 1.4125 | |
5-hydroxytryptamine receptor 3C | Homo sapiens (human) | 1.4125 | |
5-hydroxytryptamine receptor 3B | Mus musculus (house mouse) | 1.4125 | |
Transporter | Rattus norvegicus (Norway rat) | 0.022 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
1 other study(ies) available for clofibride and mianserin
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |